Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (208)

1

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

enthalten in: Annals of the rheumatic diseases | 2020

von Nuño, L. | Novella Navarro, M. | Bonilla, G. | +14

2

Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease

enthalten in: Proteins | 2020

von Lesk, A. | Konagurthu, A. | Allison, L. | +3

CommentOn: PLoS One. 2009;4(2):e4349. - PMID 19194505

3

Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome : A structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2020

von Zeng, C. | Yuan, Z. | Pan, X. | +7

4

Organoid technology demonstrates effects of potential drugs for COVID-19 on the lung regeneration

enthalten in: Cell proliferation | 2020

von Wang, J. | Li, X. | Wang, A. | +6

5

The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19

enthalten in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences | 2020

von Ashraf, M. | Sherafat, A. | Pourdast, A. | +2

6

Considerations on the Article "Antiviral and Anti-Inflammatory Properties of Ivermectin and its Potential Use in COVID-19"

enthalten in: Archivos de bronconeumologia | 2020

von Hernández-Vásquez, A. | Vargas-Fernández, R. | Azañedo, D.

CommentOn: Arch Bronconeumol. 2020 Dec;56(12):831. - PMID 32736876

7

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

enthalten in: Emerging microbes & infections | 2020

von Zhang, Y. | Zhang, Q. | Li, X. | +10

8

Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19

enthalten in: Archivos de bronconeumologia | 2020

von Portmann-Baracco, A. | Bryce-Alberti, M. | Accinelli, R.

CommentIn: Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):832. - PMID 33051096

9

Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit

enthalten in: Virologica Sinica | 2020

von Cai, Y. | Xu, W. | Gu, C. | +5

10

Fighting Hepatitis C in a COVID-19 ecosystem. Public health policies are needed more than ever

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2020

von Lopes, H. | Baptista-Leite, R. | Franco, D. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]